Allarity Therapeutics (ALLR) vs Rocket One (RKTO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Allarity Therapeutics (ALLR) has outperformed Rocket One (RKTO) over the past year, losing 42.2% versus a loss of 61.1%. Rocket One is the larger company by market cap ($16.2 million vs $15.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALLR | RKTO |
|---|---|---|
| Share price | $0.99 | $0.6493 |
| Market cap | $15.75M | $16.17M |
| 1-day change | +0.82% | +0.50% |
| YTD return | -9.08% | -34.41% |
| 1-year return | -42.24% | -61.12% |
| 5-year return | — | -97.76% |
| EPS (TTM) | $-0.79 | $-0.82 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.84 | $2.45 |
| 52-week low | $0.769 | $0.489 |
| Distance from 52-week high | -46.20% | -73.50% |
| Analyst consensus | none | — |
| Avg. price target upside | +1011.11% | — |
| Average volume | 90.75K | 630.66K |
| Shares outstanding | 15.91M | 24.90M |
| Employees | 7 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ALLR has outperformed RKTO by 18.9 percentage points over the past year.
About Allarity Therapeutics
ALLR stock →Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology.
Health Care · Biotechnology: Pharmaceutical Preparations · 7 employees
About Rocket One
RKTO stock →Rocket One Inc. focuses on developing and commercializing AI semiconductor infrastructure.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
ALLR vs RKTO FAQ
Which is bigger, Allarity Therapeutics or Rocket One?
Rocket One (RKTO) is larger, with a market capitalization of $16.17M compared with $15.75M for Allarity Therapeutics (ALLR).
Which stock has performed better over the past year, ALLR or RKTO?
ALLR returned -42.24% over the past 12 months, compared with -61.12% for RKTO (price return, excluding dividends). Past performance does not predict future results.
Are Allarity Therapeutics and Rocket One in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.